-
2
-
-
0037424703
-
-
(a) Harada, H.; Hirokawa, Y.; Suzuki, K.; Hiyama, Y.; Oue, M.; Kawashima, H.; Yoshida, N.; Furutani, Y.; Kato, S. Bioorg. Med. Chem. Lett. 2003, 13, 1301.
-
(2003)
Bioorg. Med. Chem. Lett
, vol.13
, pp. 1301
-
-
Harada, H.1
Hirokawa, Y.2
Suzuki, K.3
Hiyama, Y.4
Oue, M.5
Kawashima, H.6
Yoshida, N.7
Furutani, Y.8
Kato, S.9
-
3
-
-
21044449411
-
-
(b) Harada, H.; Hirokawa, Y.; Suzuki, K.; Hiyama, Y.; Oue, M.; Kawashima, H.; Kato, H.; Yoshida, N.; Furutani, Y.; Kato, S. Chem. Pharm. Bull. 2005, 53, 184.
-
(2005)
Chem. Pharm. Bull
, vol.53
, pp. 184
-
-
Harada, H.1
Hirokawa, Y.2
Suzuki, K.3
Hiyama, Y.4
Oue, M.5
Kawashima, H.6
Kato, H.7
Yoshida, N.8
Furutani, Y.9
Kato, S.10
-
5
-
-
8344262482
-
-
For the latest drug therapy for diabetes, see:, Oct 25
-
For the latest drug therapy for diabetes, see: Dalton, L. W. Chem. Eng. News 2004, 82 (Oct 25), 59.
-
(2004)
Chem. Eng. News
, Issue.82
, pp. 59
-
-
Dalton, L.W.1
-
6
-
-
33847757062
-
-
In its discovery synthesis, AJ-9677 (2) was elaborated in a linear fashion as described in ref 2.
-
In its discovery synthesis, AJ-9677 (2) was elaborated in a linear fashion as described in ref 2.
-
-
-
-
7
-
-
1842473183
-
-
Harada, H.; Fujii, A.; Odai, O.; Kato, S. Org. Process Res. Dev. 2004, 8, 238.
-
(2004)
Org. Process Res. Dev
, vol.8
, pp. 238
-
-
Harada, H.1
Fujii, A.2
Odai, O.3
Kato, S.4
-
8
-
-
0035931028
-
-
Fujii, A.; Fujima, Y.; Harada, H.; Ikunaka, M.; Inoue, T.; Kato, S.; Matsuyama, K. Tetrahedron: Asymmetry 2001, 12, 3235.
-
(2001)
Tetrahedron: Asymmetry
, vol.12
, pp. 3235
-
-
Fujii, A.1
Fujima, Y.2
Harada, H.3
Ikunaka, M.4
Inoue, T.5
Kato, S.6
Matsuyama, K.7
-
9
-
-
33847746608
-
-
Murakami, Y, Ikeda, T, Inagaki, T, Beta-Chem, Inc. and Katayama Seiyakusho Co, Ltd, Jpn. Kokai Tokkyo Koho 2005-281,237, 2005
-
Murakami, Y.; Ikeda, T.; Inagaki, T. (Beta-Chem, Inc. and Katayama Seiyakusho Co., Ltd.). Jpn. Kokai Tokkyo Koho 2005-281,237, 2005.
-
-
-
-
10
-
-
0037220344
-
-
Harada, H.; Fujii, A.; Kato, S. Synth. Commun. 2003, 33, 507.
-
(2003)
Synth. Commun
, vol.33
, pp. 507
-
-
Harada, H.1
Fujii, A.2
Kato, S.3
-
11
-
-
33847704851
-
-
Watanabe, H, Aritoku, Y, Hirosue, S, Fujii, T, Uematsu, H, Issiki, K, Yoshioka, T, Mercian Corporation, Jpn. Kokai Tokkyo Koho 2001-95,577, 2001
-
(a) Watanabe, H.; Aritoku, Y.; Hirosue, S.; Fujii, T.; Uematsu, H.; Issiki, K.; Yoshioka, T. (Mercian Corporation). Jpn. Kokai Tokkyo Koho 2001-95,577, 2001.
-
-
-
-
12
-
-
4544326938
-
-
(b) Sugimori, D.; Sekiguchi, T.; Hasumi, F.; Kubo, M.; Shirasaka, N.; Ikunaka, M. Biosci. Biotechnol. Biochem. 2004, 68, 1167.
-
(2004)
Biosci. Biotechnol. Biochem
, vol.68
, pp. 1167
-
-
Sugimori, D.1
Sekiguchi, T.2
Hasumi, F.3
Kubo, M.4
Shirasaka, N.5
Ikunaka, M.6
-
14
-
-
33847702045
-
-
This review article is based in part on the lecture entitled, Two Case Studies on Process Development with Resolution via Diastereomeric Salt Formation: Their Chronological and Multifaceted Description to Identify the Real Competitiveness which was given by M.I. at The 2005 Winter Symposium of the Japanese Society for Process Chemistry, Osaka, December 8, 2005
-
This review article is based in part on the lecture entitled ''Two Case Studies on Process Development with Resolution via Diastereomeric Salt Formation: Their Chronological and Multifaceted Description to Identify the Real Competitiveness" which was given by M.I. at The 2005 Winter Symposium of the Japanese Society for Process Chemistry, Osaka, December 8, 2005.
-
-
-
-
15
-
-
33644994700
-
-
For the production of D-Ala, see
-
For the production of D-Ala, see: Ikunaka, M. chimica oggi/Chemistry Today 2005, 23, 58.
-
(2005)
chimica oggi/Chemistry Today
, vol.23
, pp. 58
-
-
Ikunaka, M.1
-
16
-
-
33744718772
-
-
Yamada, Y.; Arima, S.; Okada, C.; Akiba, A.; Kai, T.; Harigaya, Y. Chem. Pharm Bull. 2006, 54, 788.
-
(2006)
Chem. Pharm Bull
, vol.54
, pp. 788
-
-
Yamada, Y.1
Arima, S.2
Okada, C.3
Akiba, A.4
Kai, T.5
Harigaya, Y.6
-
17
-
-
84989996015
-
-
Kalir, A.; Balderman, D.; Edery, H.; Porath, G. Isr. J. Chem. 1967, 5, 129.
-
(1967)
Isr. J. Chem
, vol.5
, pp. 129
-
-
Kalir, A.1
Balderman, D.2
Edery, H.3
Porath, G.4
-
18
-
-
0030737815
-
-
Ebbers, E. J.; Ariaans, G. J. A.; Houbiers, J. P. M.; Bruggink, A.; Zwanenburg, B. Tetrahedron 1997, 53, 9417.
-
(1997)
Tetrahedron
, vol.53
, pp. 9417
-
-
Ebbers, E.J.1
Ariaans, G.J.A.2
Houbiers, J.P.M.3
Bruggink, A.4
Zwanenburg, B.5
-
19
-
-
13844267575
-
-
For the racemization of a chiral primary amine over Raney Ni, see
-
For the racemization of a chiral primary amine over Raney Ni, see: Hirayama, Y.; Ikunaka, M.; Matsumoto, J. Org. Process Res. Dev. 2005, 9, 30.
-
(2005)
Org. Process Res. Dev
, vol.9
, pp. 30
-
-
Hirayama, Y.1
Ikunaka, M.2
Matsumoto, J.3
-
21
-
-
22244486966
-
-
Fogassy, E.; Nógrádi, M.; Pálovics, E.; Schindler, J. Synthesis 2005, 1555.
-
(2005)
Synthesis
, pp. 1555
-
-
Fogassy, E.1
Nógrádi, M.2
Pálovics, E.3
Schindler, J.4
-
22
-
-
33847692696
-
-
Yamaguchi, T.; Ban, M.; Yanagi, T.; Kikuchi, K.; Kubota, M.; Ozawa, T. (Kissei Pharmaceutical Co., Ltd.). WO 2004/005251.
-
Yamaguchi, T.; Ban, M.; Yanagi, T.; Kikuchi, K.; Kubota, M.; Ozawa, T. (Kissei Pharmaceutical Co., Ltd.). WO 2004/005251.
-
-
-
-
23
-
-
33847734667
-
-
Kato, S, Harada, H, Fujii, A, Odai, O, Dainippon Pharmaceutical Co, Ltd, Jpn. Kokai Tokkyo Koho 1999-2,551,743, 1999
-
Kato, S.; Harada, H.; Fujii, A.; Odai, O. (Dainippon Pharmaceutical Co., Ltd.). Jpn. Kokai Tokkyo Koho 1999-2,551,743, 1999.
-
-
-
-
25
-
-
0025907731
-
-
For other relevant approaches, see
-
For other relevant approaches, see: Dobson, D.; Todd, A.; Gilmore, J. Synth. Commun. 1991, 21, 611.
-
(1991)
Synth. Commun
, vol.21
, pp. 611
-
-
Dobson, D.1
Todd, A.2
Gilmore, J.3
-
27
-
-
0037016989
-
-
(a) Yang, C.-G.; Wang, J.; Jiang, B. Tetrahedron Lett. 2002, 43, 1063.
-
(2002)
Tetrahedron Lett
, vol.43
, pp. 1063
-
-
Yang, C.-G.1
Wang, J.2
Jiang, B.3
-
28
-
-
33847757059
-
-
(b) Sasaki, M.; Nodera, K.; Mukai, K.; Yoshioka, H. Bull. Chem. Soc. Jpn. 1977, 50, 276.
-
(1977)
Bull. Chem. Soc. Jpn
, vol.50
, pp. 276
-
-
Sasaki, M.1
Nodera, K.2
Mukai, K.3
Yoshioka, H.4
-
31
-
-
0000618755
-
-
For an oxidative version of the cyclative functionalization, see
-
For an oxidative version of the cyclative functionalization, see: Romero, A. G.; Darlington, W. H.; McMillan, M. W. J. Org. Chem. 1997, 62, 6582.
-
(1997)
J. Org. Chem
, vol.62
, pp. 6582
-
-
Romero, A.G.1
Darlington, W.H.2
McMillan, M.W.3
-
32
-
-
84985502132
-
-
Reissenweber, G.; Mangold, D. Angew. Chem., Int. Ed. Engl. 1980, 19, 222.
-
(1980)
Angew. Chem., Int. Ed. Engl
, vol.19
, pp. 222
-
-
Reissenweber, G.1
Mangold, D.2
-
33
-
-
0036326850
-
-
For alternative methods for indoline dehydrogenation, see
-
For alternative methods for indoline dehydrogenation, see: Tilstam, U.; Weinmann, H. Org. Process Res. Dev. 2002, 6, 384.
-
(2002)
Org. Process Res. Dev
, vol.6
, pp. 384
-
-
Tilstam, U.1
Weinmann, H.2
-
34
-
-
0004232165
-
-
2nd ed, Ager, D, Ed, CRC Press: Boca Raton, FL
-
Handbook of Chiral Chemicals, 2nd ed.; Ager, D., Ed.; CRC Press: Boca Raton, FL, 2006.
-
(2006)
Handbook of Chiral Chemicals
-
-
|